I have strong expertise on PMx model development, ranging from translational sciences up to Phase-III applied in many therapeutic areas and for various molecular entities.
I have experience on meta-analyses, for example to position a drug in its competitive landscape. This includes model-based meta-analyses (MBMA) to address some of the underlying biology and to overcome missing information.
I can help to utilize your PMx model for example to assess the efficacy and safety of a compound or to provide predictions for virtual populations. Also, to maximize the value of your PMx model, I can convert the model into a simple but effective R-Shiny app.
I can offer independent Quality Control services of PMx models, R-scripts, and M&S reports to ensure your PMx analyses are correct and of high quality.